Schedule of Error Corrections and Prior Period Adjustments | 18. Immaterial Restatement of Prior Period Financial Statements As discussed in Note 1, we identified errors in our consolidated financial statements for fiscal years ended 2022 and 2021 and for the quarterly periods of 2023. A summary of the corrections, inclusive of adjustments discovered in the third and fourth quarters of 2023, are as follows (tables may not foot or cross foot due to rounding): Condensed Consolidated Balance Sheet January 1, 2022 As Previously Reported Adjustments As Corrected Assets Cash and cash equivalents $ 601,428 $ (13,378) $ 588,050 Receivables, net 782,785 (28,671) 754,114 Inventories, net 4,659,018 23,617 4,682,635 Total current assets 6,275,476 (18,432) 6,257,044 Total assets $ 12,194,209 $ (18,432) $ 12,175,777 Liabilities and Stockholders’ Equity Accounts payable $ 3,922,007 $ 44,567 $ 3,966,574 Accrued expenses 777,051 (2,902) 774,149 Total current liabilities 5,180,307 41,665 5,221,972 Deferred income taxes 410,606 (15,438) 395,168 Other long-term liabilities 103,034 1,840 104,874 Total liabilities 9,065,918 28,067 9,093,985 Accumulated other comprehensive loss (22,627) (4,432) (27,059) Retained earnings 4,605,791 (42,067) 4,563,724 Total stockholders’ equity 3,128,291 (46,499) 3,081,792 Total liabilities and stockholders’ equity $ 12,194,209 $ (18,432) $ 12,175,777 Condensed Consolidated Balance Sheet December 31, 2022 As Previously Reported Adjustments As Corrected Assets Cash and cash equivalents $ 269,282 $ 1,523 $ 270,805 Receivables, net 698,613 (14,565) 684,048 Inventories, net 4,915,262 (18,993) 4,896,269 Total current assets 6,046,852 (32,035) 6,014,817 Total assets $ 12,018,482 $ (32,035) $ 11,986,447 Liabilities and Stockholders’ Equity Accounts payable $ 4,123,462 $ 55,445 $ 4,178,907 Accrued expenses 634,447 (4,983) 629,464 Total current liabilities 5,370,389 50,462 5,420,851 Deferred income taxes 415,997 (5,248) 410,749 Other long-term liabilities 87,214 1,840 89,054 Total liabilities 9,340,201 47,054 9,387,255 Accumulated other comprehensive loss (45,143) 448 (44,695) Retained earnings 4,744,624 (79,537) 4,665,087 Total stockholders’ equity 2,678,281 (79,089) 2,599,192 Total liabilities and stockholders’ equity $ 12,018,482 $ (32,035) $ 11,986,447 Condensed Consolidated Balance Sheet April 22, 2023 As Previously Reported Adjustments As Corrected Assets Cash and cash equivalents $ 226,499 $ (2,619) $ 223,880 Receivables, net 782,093 (12,107) 769,986 Inventories, net 5,015,973 (14,816) 5,001,157 Other current assets 177,127 24,590 201,717 Total current assets 6,201,692 (4,952) 6,196,740 Total assets $ 12,182,238 $ (4,952) $ 12,177,286 Liabilities and Stockholders’ Equity Accounts payable $ 3,682,749 $ 72,249 $ 3,754,998 Accrued expenses 718,290 (352) 717,938 Total current liabilities 4,983,455 71,897 5,055,352 Deferred income taxes 422,984 (5,248) 417,736 Other long-term liabilities 85,762 1,840 87,602 Total liabilities 9,546,077 68,489 9,614,566 Accumulated other comprehensive loss (44,355) 424 (43,931) Retained earnings 4,697,697 (73,865) 4,623,832 Total stockholders’ equity 2,636,161 (73,441) 2,562,720 Total liabilities and stockholders’ equity $ 12,182,238 $ (4,952) $ 12,177,286 Condensed Consolidated Balance Sheet July 15, 2023 As Previously Reported Adjustments As Corrected Assets Cash and cash equivalents $ 277,064 $ (1,838) $ 275,226 Receivables, net 793,772 (11,081) 782,691 Inventories, net 5,067,467 (15,223) 5,052,244 Other current assets 188,169 22,988 211,157 Total current assets 6,326,472 (5,154) 6,321,318 Total assets $ 12,304,376 $ (5,154) $ 12,299,222 Liabilities and Stockholders’ Equity Accounts payable $ 3,780,215 $ 82,467 $ 3,862,682 Accrued expenses 685,191 (7,088) 678,103 Total current liabilities 5,026,378 75,379 5,101,757 Total liabilities 9,581,189 75,379 9,656,568 Accumulated other comprehensive loss (36,824) 117 (36,707) Retained earnings 4,767,168 (80,650) 4,686,518 Total stockholders’ equity 2,723,187 (80,533) 2,642,654 Total liabilities and stockholders’ equity $ 12,304,376 $ (5,154) $ 12,299,222 Condensed Consolidated Balance Sheet October 7, 2023 As Previously Reported Adjustments As Corrected Assets Cash and cash equivalents $ 317,528 $ (974) $ 316,554 Receivables, net 868,305 (5,045) 863,260 Inventories, net 4,949,382 (30,227) 4,919,155 Other current assets 185,249 36,475 221,724 Total current assets 6,320,464 229 6,320,693 Total assets $ 12,248,932 $ 229 $ 12,249,161 Liabilities and Stockholders’ Equity Accounts payable $ 3,943,019 $ 70,995 $ 4,014,014 Accrued expenses 714,317 9,766 724,083 Total current liabilities 5,135,939 80,761 5,216,700 Total liabilities 9,602,064 80,761 9,682,825 Accumulated other comprehensive loss (47,599) 574 (47,025) Retained earnings 4,690,424 (81,106) 4,609,318 Total stockholders’ equity 2,646,868 (80,532) 2,566,336 Total liabilities and stockholders’ equity $ 12,248,932 $ 229 $ 12,249,161 Condensed Consolidated Statement of Operations January 1, 2022 Year Ended As Previously Reported Adjustments As Corrected Cost of sales $ 6,069,241 $ 4,798 $ 6,074,039 Gross profit 4,928,748 (4,798) 4,923,950 Selling, general and administrative expenses 4,090,031 11,554 4,101,585 Operating income 838,717 (16,352) 822,365 Other (expense) income, net 4,999 (7,080) (2,081) Total other, net (32,792) (7,080) (39,872) Income before provision for income taxes 805,925 (23,432) 782,493 Provision for income taxes 189,817 (3,939) 185,878 Net income $ 616,108 $ (19,493) $ 596,615 Basic earnings per share $ 9.62 $ (0.30) $ 9.32 Diluted earnings per common share $ 9.55 $ (0.30) $ 9.25 Condensed Consolidated Statement of Operations December 31, 2022 Year Ended As Previously Reported Adjustments As Corrected Cost of sales $ 6,192,622 $ 29,865 $ 6,222,487 Gross profit 4,962,100 (29,865) 4,932,235 Selling, general and administrative expenses 4,247,949 14,033 4,261,982 Operating income 714,151 (43,898) 670,253 Other (expense) income, net (6,996) (427) (7,423) Total other, net (65,464) (427) (65,891) Income before provision for income taxes 648,687 (44,325) 604,362 Provision for income taxes 146,815 (6,855) 139,960 Net income $ 501,872 $ (37,470) $ 464,402 Basic earnings per share $ 8.32 $ (0.62) $ 7.70 Diluted earnings per common share $ 8.27 $ (0.62) $ 7.65 Condensed Consolidated Statement of Operations April 22, 2023 Sixteen Weeks Ended As Previously Reported Adjustments As Corrected Cost of sales $ 1,946,931 $ 8,735 $ 1,955,666 Gross profit 1,470,663 (8,735) 1,461,928 Selling, general and administrative expenses 1,380,664 (16,674) 1,363,990 Operating income 89,999 7,939 97,938 Income before provision for income taxes 59,607 7,939 67,546 Provision for income taxes 16,956 2,267 19,223 Net income $ 42,651 $ 5,672 $ 48,323 Basic earnings per share $ 0.72 $ 0.09 $ 0.81 Diluted earnings per common share $ 0.72 $ 0.09 $ 0.81 Condensed Consolidated Statement of Operations July 15, 2023 Twelve Weeks Ended Twenty-Eight Weeks Ended As Previously Reported Adjustments As Corrected As Previously Reported Adjustments As Corrected Cost of sales $ 1,537,997 $ 7,614 $ 1,545,611 $ 3,484,927 $ 16,350 $ 3,501,277 Gross profit 1,148,069 (7,614) 1,140,455 2,618,732 (16,350) 2,602,382 Selling, general and administrative expenses 1,013,701 794 1,014,495 2,394,365 (15,881) 2,378,484 Operating income 134,368 (8,408) 125,960 224,367 (469) 223,898 Income before provision for income taxes 115,183 (8,408) 106,775 174,789 (469) 174,320 Provision for income taxes 29,821 (1,623) 28,198 46,776 644 47,420 Net income $ 85,362 $ (6,785) $ 78,577 $ 128,013 $ (1,113) $ 126,900 Basic earnings per share $ 1.44 $ (0.12) $ 1.32 $ 2.16 $ (0.02) $ 2.14 Diluted earnings per common share $ 1.43 $ (0.11) $ 1.32 $ 2.15 $ (0.02) $ 2.13 Condensed Consolidated Statement of Operations October 7, 2023 Twelve Weeks Ended Forty Weeks Ended As Previously Reported Adjustments As Corrected As Previously Reported Adjustments As Corrected Cost of sales $ 1,732,420 $ 16,379 $ 1,748,799 $ 5,220,200 $ 29,877 $ 5,250,077 Gross profit 986,659 (16,379) 970,280 3,602,538 (29,877) 3,572,661 Selling, general and administrative expenses 1,030,355 878 1,031,233 3,407,445 2,272 3,409,717 Operating (loss) income (43,696) (17,257) (60,953) 195,093 (32,149) 162,944 (Loss) income before provision for income taxes (64,319) (17,257) (81,576) 124,894 (32,149) 92,745 Provision for income taxes (15,686) (3,853) (19,539) 34,649 (6,766) 27,883 Net (loss) income $ (48,633) $ (13,404) $ (62,037) $ 90,245 $ (25,383) $ 64,862 Basic (loss) earnings per share $ (0.82) $ (0.22) $ (1.04) $ 1.52 $ (0.43) $ 1.09 Diluted (loss) earnings per common share $ (0.82) $ (0.22) $ (1.04) $ 1.51 $ (0.42) $ 1.09 Condensed Consolidated Statement of Comprehensive Income January 1, 2022 Year Ended As Previously Reported Adjustments As Corrected Net income $ 616,108 $ (19,493) $ 596,615 Currency translation adjustments 4,396 (4,455) (59) Total other comprehensive income (loss) 4,132 (4,455) (323) Comprehensive income $ 620,240 $ (23,948) $ 596,292 Condensed Consolidated Statement of Comprehensive Income December 31, 2022 Year Ended As Previously Reported Adjustments As Corrected Net income $ 501,872 $ (37,470) $ 464,402 Currency translation adjustments (22,330) 4,880 (17,450) Total other comprehensive loss (22,516) 4,880 (17,636) Comprehensive income $ 479,356 $ (32,590) $ 446,766 Condensed Consolidated Statement of Comprehensive Income April 22, 2023 Sixteen Weeks Ended As Previously Reported Adjustments As Corrected Net income $ 42,651 $ 5,672 $ 48,323 Currency translation adjustments 591 (24) 567 Total other comprehensive loss 788 (24) 764 Comprehensive income $ 43,439 $ 5,648 $ 49,087 Condensed Consolidated Statement of Comprehensive Income July 15, 2023 Twelve Weeks Ended Twenty-Eight Weeks Ended As Previously Reported Adjustments As Corrected As Previously Reported Adjustments As Corrected Net income $ 85,362 $ (6,785) $ 78,577 $ 128,013 $ (1,113) $ 126,900 Currency translation adjustments 7,569 (307) 7,262 8,160 (331) 7,829 Total other comprehensive income 7,531 (307) 7,224 8,319 (331) 7,988 Comprehensive income $ 92,893 $ (7,092) $ 85,801 $ 136,332 $ (1,444) $ 134,888 Condensed Consolidated Statement of Comprehensive Income October 7, 2023 Twelve Weeks Ended Forty Weeks Ended As Previously Reported Adjustments As Corrected As Previously Reported Adjustments As Corrected Net (loss) income $ (48,633) $ (13,404) $ (62,037) $ 90,245 $ (25,383) $ 64,862 Currency translation adjustments (10,737) 457 (10,280) (2,577) 126 (2,451) Total other comprehensive loss (10,775) 457 (10,318) (2,456) 126 (2,330) Comprehensive (loss) income $ (59,408) $ (12,947) $ (72,355) $ 87,789 $ (25,257) $ 62,532 Condensed Consolidated Statements of Changes in Stockholders’ Equity Accumulated Other Retained Total Stockholders' Equity Fifty-Two Weeks As Previously Reported Balance at January 2, 2021 $ (26,759) $ 4,196,634 $ 3,559,512 Net income — 616,108 616,108 Total other comprehensive income 4,132 — 4,132 Balance at January 1, 2022 $ (22,627) $ 4,605,791 $ 3,128,291 Adjustments Balance at January 2, 2021 $ 23 $ (22,574) $ (22,551) Net Income — (19,493) (19,493) Total other comprehensive income (4,455) — (4,455) Balance at January 1, 2022 $ (4,432) $ (42,067) $ (46,499) As Corrected Balance at January 2, 2021 $ (26,736) $ 4,174,060 $ 3,536,961 Net income — 596,615 596,615 Total other comprehensive loss (323) — (323) Balance at January 1, 2022 $ (27,059) $ 4,563,724 $ 3,081,792 Condensed Consolidated Statements of Changes in Stockholders’ Equity Accumulated Other Retained Total Stockholders' Equity Fifty-Two Weeks As Previously Reported Balance at January 1, 2022 $ (22,627) $ 4,605,791 $ 3,128,291 Net income — 501,872 501,872 Total other comprehensive loss (22,516) — (22,516) Balance at December 31, 2022 $ (45,143) $ 4,744,624 $ 2,678,281 Adjustments Balance at January 1, 2022 $ (4,432) $ (42,067) $ (46,499) Net Income — (37,470) (37,470) Total other comprehensive loss 4,880 — 4,880 Balance at December 31, 2022 $ 448 $ (79,537) $ (79,089) As Corrected Balance at January 1, 2022 $ (27,059) $ 4,563,724 $ 3,081,792 Net income — 464,402 464,402 Total other comprehensive loss (17,636) — (17,636) Balance at December 31, 2022 $ (44,695) $ 4,665,087 $ 2,599,192 Condensed Consolidated Statements of Changes in Stockholders’ Equity Sixteen Weeks Ended April 22, 2023 Accumulated Other Retained Total Stockholders' Equity Sixteen Weeks As Previously Reported Balance at December 31, 2022 $ (45,143) $ 4,744,624 $ 2,678,281 Net income — 42,651 42,651 Total other comprehensive income 788 — 788 Balance at April 22, 2023 $ (44,355) $ 4,697,697 $ 2,636,161 Adjustments Balance at December 31, 2022 $ 448 $ (79,537) $ (79,089) Net income — 5,672 5,672 Total other comprehensive income (24) — (24) Balance at April 22, 2023 $ 424 $ (73,865) $ (73,441) As Corrected Balance at December 31, 2022 $ (44,695) $ 4,665,087 $ 2,599,192 Net income — 48,323 48,323 Total other comprehensive income 764 — 764 Balance at April 22, 2023 $ (43,931) $ 4,623,832 $ 2,562,720 Condensed Consolidated Statements of Changes in Stockholders’ Equity Twelve Weeks Ended July 15, 2023 Accumulated Other Retained Total Stockholders' Equity Twelve Weeks As Previously Reported Balance at April 22, 2023 $ (44,355) $ 4,697,697 $ 2,636,161 Net income — 85,362 85,362 Total other comprehensive income 7,531 — 7,531 Balance at July 15, 2023 $ (36,824) $ 4,767,168 $ 2,723,187 Adjustments Balance at April 22, 2023 $ 424 $ (73,865) $ (73,441) Net income — (6,785) (6,785) Total other comprehensive income (307) — (307) Balance at July 15, 2023 $ 117 $ (80,650) $ (80,533) As Corrected Balance at April 22, 2023 $ (43,931) $ 4,623,832 $ 2,562,720 Net income — 78,577 78,577 Total other comprehensive income 7,224 — 7,224 Balance at July 15, 2023 $ (36,707) $ 4,686,518 $ 2,642,654 Condensed Consolidated Statements of Changes in Stockholders’ Equity Twenty-Eight Weeks Ended July 15, 2023 Accumulated Other Retained Total Stockholders' Equity Twenty-Eight Weeks As Previously Reported Balance at Dec 31, 2022 $ (45,143) $ 4,744,624 $ 2,678,281 Net income — 128,013 128,013 Total other comprehensive income 8,319 — 8,319 Balance at July 15, 2023 $ (36,824) $ 4,767,168 $ 2,723,187 Adjustments Balance at Dec 31, 2022 $ 448 $ (79,537) $ (79,089) Net income — (1,113) (1,113) Total other comprehensive income (331) — (331) Balance at July 15, 2023 $ 117 $ (80,650) $ (80,533) As Corrected Balance at Dec 31, 2022 $ (44,695) $ 4,665,087 $ 2,599,192 Net income — 126,900 126,900 Total other comprehensive income 7,988 — 7,988 Balance at July 15, 2023 $ (36,707) $ 4,686,518 $ 2,642,654 Condensed Consolidated Statements of Changes in Stockholders’ Equity Twelve Weeks Ended October 7, 2023 Accumulated Other Retained Total Stockholders' Equity Twelve Weeks As Previously Reported Balance at July 15, 2023 $ (36,824) $ 4,767,168 $ 2,723,187 Net loss — (48,633) (48,633) Total other comprehensive loss (10,775) — (10,775) Balance at October 7, 2023 $ (47,599) $ 4,690,424 $ 2,646,868 Adjustments Balance at July 15, 2023 $ 117 $ (80,650) $ (80,533) Net loss (1) — (13,404) (13,404) Total other comprehensive loss 457 — 457 Balance at October 7, 2023 $ 574 $ (81,106) $ (80,532) As Corrected Balance at July 15, 2023 $ (36,707) $ 4,686,518 $ 2,642,654 Net loss — (62,037) (62,037) Total other comprehensive loss (10,318) — (10,318) Balance at October 7, 2023 $ (47,025) $ 4,609,318 $ 2,566,336 (1) Adjustments to retained earnings do not foot due to the previous adjustments made in third quarter 2023. Condensed Consolidated Statements of Changes in Stockholders’ Equity Forty Weeks Ended October 7, 2023 Accumulated Other Retained Total Stockholders' Equity Forty Weeks As Previously Reported Balance at December 31, 2022 $ (45,143) $ 4,744,624 $ 2,678,281 Net income — 90,245 90,245 Total other comprehensive loss (2,456) — (2,456) Balance at October 7, 2023 $ (47,599) $ 4,690,424 $ 2,646,868 Adjustments Balance at December 31, 2022 $ 448 $ (79,537) $ (79,089) Net income (1) — (25,383) (25,383) Total other comprehensive loss 126 — 126 Balance at October 7, 2023 $ 574 $ (81,106) $ (80,532) As Corrected Balance at December 31, 2022 $ (44,695) $ 4,665,087 $ 2,599,192 Net income — 64,862 64,862 Total other comprehensive loss (2,330) — (2,330) Balance at October 7, 2023 $ (47,025) $ 4,609,318 $ 2,566,336 (1) Adjustments to retained earnings do not foot due to the previous adjustments made in third quarter 2023. Condensed Consolidated Statement of Cash Flows Fifty-Two Weeks Ended January 1, 2022 As Previously Reported Adjustments As Corrected Net income $ 616,108 $ (19,493) $ 596,615 Provision for deferred income taxes 68,202 (9,416) 58,786 Net change in: Receivables, net (32,652) 25,196 (7,456) Inventories, net (120,272) (3,867) (124,139) Accounts payable 281,064 9,978 291,042 Accrued expenses 109,983 (7,638) 102,345 Net cash provided by operating activities 1,112,262 (5,240) 1,107,022 Effect of exchange rate changes on cash 5,600 (126) 5,474 Net (decrease) increase in cash and cash equivalents (233,564) (5,366) (238,930) Cash and cash equivalents, beginning of period 834,992 (8,012) 826,980 Cash and cash equivalents, end of period $ 601,428 $ (13,378) $ 588,050 Condensed Consolidated Statement of Cash Flows Fifty-Two Weeks Ended December 31, 2022 As Previously Reported Adjustments As Corrected Net income $ 501,872 $ (37,470) $ 464,402 Provision for deferred income taxes 6,338 10,190 16,528 Net change in: Receivables, net 81,254 (14,107) 67,147 Inventories, net (272,253) 42,610 (229,643) Accounts payable 212,568 15,206 227,774 Accrued expenses (165,643) (2,080) (167,723) Net cash provided by operating activities 722,222 14,349 736,571 Effect of exchange rate changes on cash (9,216) 552 (8,664) Net (decrease) increase in cash and cash equivalents (332,146) 14,901 (317,245) Cash and cash equivalents, beginning of period 601,428 (13,378) 588,050 Cash and cash equivalents, end of period $ 269,282 $ 1,523 $ 270,805 Condensed Consolidated Statement of Cash Flows Sixteen Weeks Ended April 22, 2023 As Previously Reported Adjustments As Corrected Net income $ 42,651 $ 5,672 $ 48,323 Other, net 391 458 849 Net change in: Receivables, net (83,370) (2,457) (85,827) Inventories, net (100,178) (4,177) (104,355) Accounts payable (440,995) 16,805 (424,190) Accrued expenses 85,035 4,631 89,666 Other assets and liabilities, net 1,534 (24,591) (23,057) Net cash used in operating activities (378,865) (3,659) (382,524) Other, net (3,919) (458) (4,377) Net cash used in financing activities 425,660 (458) 425,202 Effect of exchange rate changes on cash 93 (25) 68 Net (decrease) increase in cash and cash equivalents (42,783) (4,142) (46,925) Cash and cash equivalents, beginning of period 269,282 1,523 270,805 Cash and cash equivalents, end of period $ 226,499 $ (2,619) $ 223,880 Condensed Consolidated Statement of Cash Flows Twenty-Eight Weeks Ended July 15, 2023 As Previously Reported Adjustments As Corrected Net income $ 128,013 $ (1,113) $ 126,900 Provision for deferred income taxes 16,249 $ 5,248 $ 21,497 Other, net 1,170 $ 458 $ 1,628 Net change in: Receivables, net (93,539) (3,483) (97,022) Inventories, net (145,148) (3,770) (148,918) Accounts payable (346,808) 27,023 (319,785) Accrued expenses 120,888 (2,107) 118,781 Other assets and liabilities, net (36,008) (24,828) (60,836) Net cash used in operating activities (164,559) (2,572) (167,131) Other, net (4,073) (458) (4,531) Net cash used in financing activities 314,403 (458) 313,945 Effect of exchange rate changes on cash 1,280 (331) 949 Net (decrease) increase in cash and cash equivalents 7,782 (3,361) 4,421 Cash and cash equivalents, beginning of period 269,282 1,523 270,805 Cash and cash equivalents, end of period $ 277,064 $ (1,838) $ 275,226 Condensed Consolidated Statement of Cash Flows Forty Weeks Ended October 7, 2023 As Previously Reported Adjustments As Corrected Net income $ 90,245 $ (25,383) $ 64,862 Provision for deferred income taxes (33,059) 5,248 (27,811) Other, net 1,499 937 2,436 Net change in: Receivables, net (170,371) (9,519) (179,890) Inventories, net (41,025) 15,442 (25,583) Accounts payable (191,871) 28,500 (163,371) Accrued expenses 145,704 21,521 167,225 Other Assets and Liabilities (45,015) (38,316) (83,331) Net cash provided by operating activities 30,404 (1,570) 28,834 Other, net (4,073) (937) (5,010) Net cash used in financing activities 204,984 (937) 204,047 Effect of exchange rate changes on cash (1,942) 10 (1,932) Net (decrease) increase in cash and cash equivalents 48,246 (2,497) 45,749 Cash and cash equivalents, beginning of period 269,282 1,523 270,805 Cash and cash equivalents, end of period $ 317,528 $ (974) $ 316,554 |